These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38807132)

  • 1. Learning semi-supervised enrichment of longitudinal imaging-genetic data for improved prediction of cognitive decline.
    Seo H; Brand L; Wang H;
    BMC Med Inform Decis Mak; 2024 May; 24(Suppl 1):61. PubMed ID: 38807132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease.
    Giorgio J; Landau SM; Jagust WJ; Tino P; Kourtzi Z;
    Neuroimage Clin; 2020; 26():102199. PubMed ID: 32106025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-modal sequence learning for Alzheimer's disease progression prediction with incomplete variable-length longitudinal data.
    Xu L; Wu H; He C; Wang J; Zhang C; Nie F; Chen L
    Med Image Anal; 2022 Nov; 82():102643. PubMed ID: 36208572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Prediction of Cognitive Outcomes via Globally Aligned Imaging Biomarker Enrichments Over Progressions.
    Lu L; Elbeleidy S; Baker L; Wang H; Shen L; Heng H
    IEEE Trans Biomed Eng; 2021 Nov; 68(11):3336-3346. PubMed ID: 33819146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the progression of mild cognitive impairment to Alzheimer's disease by longitudinal magnetic resonance imaging-based dictionary learning.
    Lin Y; Huang K; Xu H; Qiao Z; Cai S; Wang Y; Huang L;
    Clin Neurophysiol; 2020 Oct; 131(10):2429-2439. PubMed ID: 32829290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal MRI analysis using a hybrid DenseNet-BiLSTM method for Alzheimer's disease prediction.
    Jomeiri A; Navin AH; Shamsi M
    Behav Brain Res; 2024 Apr; 463():114900. PubMed ID: 38341100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease diagnosis framework from incomplete multimodal data using convolutional neural networks.
    Abdelaziz M; Wang T; Elazab A
    J Biomed Inform; 2021 Sep; 121():103863. PubMed ID: 34229061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning.
    Franzmeier N; Koutsouleris N; Benzinger T; Goate A; Karch CM; Fagan AM; McDade E; Duering M; Dichgans M; Levin J; Gordon BA; Lim YY; Masters CL; Rossor M; Fox NC; O'Connor A; Chhatwal J; Salloway S; Danek A; Hassenstab J; Schofield PR; Morris JC; Bateman RJ; ; ; Ewers M
    Alzheimers Dement; 2020 Mar; 16(3):501-511. PubMed ID: 32043733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-cohort generalizability of deep and conventional machine learning for MRI-based diagnosis and prediction of Alzheimer's disease.
    Bron EE; Klein S; Papma JM; Jiskoot LC; Venkatraghavan V; Linders J; Aalten P; De Deyn PP; Biessels GJ; Claassen JAHR; Middelkoop HAM; Smits M; Niessen WJ; van Swieten JC; van der Flier WM; Ramakers IHGB; van der Lugt A; ;
    Neuroimage Clin; 2021; 31():102712. PubMed ID: 34118592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Cognitive Declines Using Longitudinally Enriched Representations for Imaging Biomarkers.
    Lu L; Elbeleidy S; Baker LZ; Wang H; Nie F
    IEEE Trans Med Imaging; 2021 Mar; 40(3):891-904. PubMed ID: 33253116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning methods for predicting progression from mild cognitive impairment to Alzheimer's disease dementia: a systematic review.
    Grueso S; Viejo-Sobera R
    Alzheimers Res Ther; 2021 Sep; 13(1):162. PubMed ID: 34583745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using machine learning to quantify structural MRI neurodegeneration patterns of Alzheimer's disease into dementia score: Independent validation on 8,834 images from ADNI, AIBL, OASIS, and MIRIAD databases.
    Popuri K; Ma D; Wang L; Beg MF
    Hum Brain Mapp; 2020 Oct; 41(14):4127-4147. PubMed ID: 32614505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Cognitive Decline for Enrichment of Alzheimer's Disease Clinical Trials.
    Tam A; Laurent C; Gauthier S; Dansereau C
    J Prev Alzheimers Dis; 2022; 9(3):400-409. PubMed ID: 35841241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer's Disease.
    Mirabnahrazam G; Ma D; Lee S; Popuri K; Lee H; Cao J; Wang L; Galvin JE; Beg MF;
    J Alzheimers Dis; 2022; 87(3):1345-1365. PubMed ID: 35466939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-modal discriminative dictionary learning for Alzheimer's disease and mild cognitive impairment.
    Li Q; Wu X; Xu L; Chen K; Yao L; Li R
    Comput Methods Programs Biomed; 2017 Oct; 150():1-8. PubMed ID: 28859825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer's Disease.
    Ezzati A; Lipton RB;
    J Alzheimers Dis; 2020; 74(1):55-63. PubMed ID: 31985462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease.
    Vasanthakumar A; Davis JW; Idler K; Waring JF; Asque E; Riley-Gillis B; Grosskurth S; Srivastava G; Kim S; Nho K; Nudelman KNH; Faber K; Sun Y; Foroud TM; Estrada K; Apostolova LG; Li QS; Saykin AJ;
    Clin Epigenetics; 2020 Jun; 12(1):84. PubMed ID: 32539856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using high-dimensional machine learning methods to estimate an anatomical risk factor for Alzheimer's disease across imaging databases.
    Casanova R; Barnard RT; Gaussoin SA; Saldana S; Hayden KM; Manson JE; Wallace RB; Rapp SR; Resnick SM; Espeland MA; Chen JC;
    Neuroimage; 2018 Dec; 183():401-411. PubMed ID: 30130645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particulate matter and episodic memory decline mediated by early neuroanatomic biomarkers of Alzheimer's disease.
    Younan D; Petkus AJ; Widaman KF; Wang X; Casanova R; Espeland MA; Gatz M; Henderson VW; Manson JE; Rapp SR; Sachs BC; Serre ML; Gaussoin SA; Barnard R; Saldana S; Vizuete W; Beavers DP; Salinas JA; Chui HC; Resnick SM; Shumaker SA; Chen JC
    Brain; 2020 Jan; 143(1):289-302. PubMed ID: 31746986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.